C4A and systemic lupus erythematosus: To predict flare-ups and assess disease activity in SLE, elevated levels of anti-double-stranded DNA antibodies (anti-dsDNA) and erythrocyte sedimentation rate, as well as decreased complement levels (C3 and C4), are commonly used [22].